These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Medication update. Slagle M South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243 [No Abstract] [Full Text] [Related]
10. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction. Ruggieri MR; Braverman AS; Pontari MA J Urol; 2005 Nov; 174(5):1743-8. PubMed ID: 16217275 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatment of urinary incontinence. Cipullo LM; Zullo F; Cosimato C; Di Spiezio Sardo A; Troisi J; Guida M Female Pelvic Med Reconstr Surg; 2014; 20(4):185-202. PubMed ID: 24978084 [TBL] [Abstract][Full Text] [Related]
12. [Bladder storage and voiding dysfunctions : Side effects of drug therapy]. Wolfesberger J; Falkensammer CE; Madersbacher S Urologe A; 2017 Apr; 56(4):456-464. PubMed ID: 28233038 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. Landis JR; Kaplan S; Swift S; Versi E J Urol; 2004 Feb; 171(2 Pt 1):752-6. PubMed ID: 14713803 [TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor antagonists in the treatment of overactive bladder. Chapple CR Urology; 2000 May; 55(5A Suppl):33-46; discussion 50. PubMed ID: 10767450 [TBL] [Abstract][Full Text] [Related]
16. [Changes in muscarinic receptors of the aging bladder]. Andersson KE; Schröder A Urologe A; 2004 May; 43(5):552-6. PubMed ID: 15098089 [TBL] [Abstract][Full Text] [Related]
17. A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. Swift S; Garely A; Dimpfl T; Payne C; Int Urogynecol J Pelvic Floor Dysfunct; 2003 Feb; 14(1):50-4; discussion 54-5. PubMed ID: 12601517 [TBL] [Abstract][Full Text] [Related]
18. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. Hegde SS; Mammen M; Jasper JR Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972 [TBL] [Abstract][Full Text] [Related]
19. Tolterodine use for symptoms of overactive bladder. Ruscin JM; Morgenstern NE Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of urinary incontinence. Thomas DR Clin Geriatr Med; 2004 Aug; 20(3):511-23, vii-viii. PubMed ID: 15341812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]